Factor v leiden homozygous genotype and pregnancy outcomes

Obstetrics and Gynecology

Volumn 114, Issue 6, 2009, Pages 1249-1253

  Biron Andréani, Christine ^a   Bauters, Anne ^a   Le Cam Duchez, Véronique ^a   Delahousse, Bénédicte ^a   Lequerrec, Agnès ^a   Dutrillaux, Fabienne ^a   Boinot, Catherine ^a   Saladin Thiron, Catherine ^a   Polack, Benoit ^a   Gruel, Yves ^a   Morange, Pierre Emmanuel ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 5;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FETUS WASTAGE; FIRST TRIMESTER PREGNANCY; FRANCE; GENE MUTATION; GENOTYPE; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; INTERVIEW; INTRAUTERINE GROWTH RETARDATION; LIVE BIRTH; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK FACTOR; SECOND TRIMESTER PREGNANCY; SOLUTIO PLACENTAE; VENOUS THROMBOEMBOLISM; CLINICAL TRIAL; COHORT ANALYSIS; EMBRYO DEATH; FETUS DEATH; GENETICS; HOMOZYGOTE; MIDDLE AGED; MULTICENTER STUDY; PREGNANCY;

ADULT; COHORT STUDIES; EMBRYO LOSS; FACTOR V; FEMALE; FETAL DEATH; FRANCE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MIDDLE AGED; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 73349119138     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181c2243d     Document Type: Article

References (24)

1. Rosendaal FR. Venous thrombosis: the role of genes, environment, and behavior. Hematology Am Soc Hematol Educ Program 2005;1-12.
2. Lockwood CJ. Inherited thrombophilias in pregnant patients: detection and treatment paradigm. Obstet Gynecol 2002;99: 333-341
3. Rodger MA, Paidas M, McLintock C, Middeldorp S, Kahn S, Martinelli I, et al. Inherited thrombophilia and pregnancy complications revisited [published erratum appears in Obstet Gynecol 2008;112:1392]. Obstet Gynecol 2008;112:320-324
4. Dudding TE, Attia J. The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis. Thromb Haemost 2004;91:700-711 (Pubitemid 38477450)
5. Kovalevsky G, Gracia CR, Berlin JA, Sammel MD, Barnhart KT. Evaluation of the association between hereditary throm-bophilias and recurrent pregnancy loss: a meta-analysis. Arch Intern Med 2004;164:558-563
6. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 2003;361:901-908
7. Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD, et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol 2006;132:171-196
8. Procare-GEHT Group. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation. Br J Haematol 2006;135:697-702.
9. De Stefano V, Rossi E, Paciaroni K, Leone G. Screening for inherited thrombophilia: indications and therapeutic implications. Haematologica 2002;87:1095-1108
10. Simpson JL. Causes of fetal wastage. Clin Obstet Gynecol 2007;50:10-30.
11. Coppens M, Folkeringa N, Teune MJ, Hamulyak K, van der Meer J, Prins MH, et al. Outcome of the subsequent pregnancy after a first loss in women with the factor V Leiden or prothrom-bin 20210A mutations. J Thromb Haemost 2007;5:1444-1448 (Pubitemid 46965373)
12. Lindqvist PG, Merlo J. The natural course of women with recurrent fetal loss. J Thromb Haemost 2006;4:896-897
13. Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. Jama 1997;277:1305-1307
14. Juul K, Tybjaerg-Hansen A, Nordestgaard BG. Factor V Leiden: relation to fertility? Lancet 2002;359:894.
15. van Dunne FM, Doggen CJ, Heemskerk M, Rosendaal FR, Helmerhorst FM. Factor V Leiden mutation in relation to fecundity and miscarriage in women with venous thrombosis. Hum Reprod 2005;20:802-806
16. Gris JC. Thrombophilia and pregnancy loss: cause or association. Thromb Res 2009;123:S105-10.
17. Dizon-Townson DS, Meline L, Nelson LM, Varner M, Ward K. Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction. Am J Obstet Gynecol 1997;177:402-405
18. Sood R, Zogg M, Westrick RJ, Guo YH, Kerschen EJ, Girardi G, et al. Fetal gene defects precipitate platelet-mediated pregnancy failure in factor V Leiden mothers. J Exp Med 2007; 204:1049-1056
19. Dizon-Townson D, Miller C, Sibai B, Spong CY, Thom E, Wendel G Jr, et al. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol 2005;106:517-524
20. Tormene D, Simioni P, Prandoni P, Luni S, Innella B, Sabbion P, Girolami A. The risk of fetal loss in family members of probands with factor V Leiden mutation. Thromb Haemost 1999;82:1237-1239
21. Brenner B. Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications-yes. J Thromb Haemost 2003;1:2070-2072
22. Middeldorp S. Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications-no. J Thromb Haemost 2003;1:2073-2074
23. Folkeringa N, Brouwer JL, Korteweg FJ, Veeger NJ, Erwich JJ, Holm JP, et al. Reduction of high fetal loss rate by anticoagulant treatment during pregnancy in antithrombin, protein C or protein S deficient women. Br J Haematol 2007;136:656-661
24. Cleary-Goldman J, Bettes B, Robinson JN, Norwitz E, Schul-kin J. Thrombophilia and the obstetric patient. Obstet Gynecol 2007;110:669-674